drugset / Trial / NCT00651768

Titratable Dosing in Moderate to Severe Asthmatics

NCT00651768

Phase 3 Completed 570 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the long term safety of Symbicort with budesonide alone, in adolescents and adults with asthma.

Timeline

Start
2003-08
Primary completion
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 640 ug Inhaled
Subject budesonide/formoterol Unknown Inhaled

Indications